About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

53.27 -0.26 (-0.48%)

Streaming Delayed Price Updated: 11:58 AM EST, Feb 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

35 36 Next >

CRISPR Therapeutics sets sights on gene-editing cures for disease

December 27, 2023

On Dec. 8, 2023, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) announced the U.S. FDA approved its sickle-cell disease (SCD) treatment, Casgevy, for

Via MarketBeat

3 Top Stocks to Buy Hand Over Fist Before the End of 2023 ↗

December 25, 2023

These are ideal stocks to buy sooner rather than later.

Via The Motley Fool

3 Healthcare Technology Stocks to Improve Lives in 2024 ↗

December 25, 2023

Healthcare technology is one of 2024's top investment trends, and investors looking for long-term upside should check out these top stocks.

Via InvestorPlace

1 Green Flag and 1 Red Flag for Bluebird Bio Stock ↗

December 23, 2023

The stock has been in the news lately.

Via The Motley Fool

Could CRISPR Therapeutics Stock Help You Become a Millionaire? ↗

December 22, 2023

There are plenty of reasons to be optimistic about CRISPR's future.

Via The Motley Fool

Where Will CRISPR Therapeutics Be in 5 Years? ↗

December 15, 2023

Does the recent approval make the stock a no-brainer buy?

Via The Motley Fool

After This Landmark Win, Is CRISPR Therapeutics a Buy? ↗

December 15, 2023

CRISPR Therapeutics stock already has advanced in the double digits this year.

Via The Motley Fool

Cathie Wood Predicts Deflation In 2024, More AI And Tech Optimism — And Rate Cuts ↗

December 22, 2023

Cathie Wood believes deflation in 2024, aggressive rate cuts and technological progress will drive expansion.

Via Benzinga

Topics Artificial Intelligence Economy

3 Money-Saving Tricks for Investing in Biotech Stocks in 2024 ↗

December 22, 2023

Doing a little math and doing a little extra research can make a big difference.

Via The Motley Fool

I'm Begging You to Buy Stocks Before January -- Here's Why ↗

December 22, 2023

Some studies have shown a pattern of market gains in the month of January.

Via The Motley Fool

Up More Than 60% in 2023, Is It Too Late to Buy This Soaring Biotech Stock? ↗

December 22, 2023

The FDA's recent approval of CRISPR Therapeutics' first therapy is a step in the right direction.

Via The Motley Fool

6 Words That Explain Why CRISPR Stock Isn't Soaring Despite the Recent FDA Approval for Its Gene-Editing Therapy ↗

December 21, 2023

Should you buy CRISPR's stock on the dip?

Via The Motley Fool

Better Bull Market Buy: CRISPR Therapeutics vs. Pfizer Stock ↗

December 21, 2023

These stocks are currently going in different directions, but both could go up in a new bull market.

Via The Motley Fool

Is Vertex Pharmaceuticals Sitting on a Gold Mine? ↗

December 21, 2023

Vertex shares have climbed about 40% this year.

Via The Motley Fool

CRSP Stock Alert: CRISPR Therapeutics Is Losing Its Medical Chief ↗

December 20, 2023

The fate of Crispr and CRSP stock will be determined by the success of other drugs in the company's pipeline rather than Casgevy.

Via InvestorPlace

3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow ↗

December 20, 2023

CRISPR Therapeutics stock has increased in the double digits this year.

Via The Motley Fool

3 Genomics Stocks to Unlock the Future of Medicine ↗

December 19, 2023

Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use.

Via InvestorPlace

Better Growth Stock: Archer Aviation or Prime Medicine? ↗

December 19, 2023

Which of these innovation-themed growth stocks is the better buy?

Via The Motley Fool

3 Healthcare Stocks That Could Help Make You a Millionaire ↗

December 19, 2023

These stocks each have reached an important turning point that could signal growth ahead.

Via The Motley Fool

2 Stocks Profiting From Unstoppable Trends That Could Make You Rich ↗

December 18, 2023

It's important to choose companies involved in trends that have long-term potential.

Via The Motley Fool

2 Stocks That Could Turn $1,000 Into $3,500 in 10 Years ↗

December 17, 2023

These businesses are exciting and can also lead to outsized long-term returns.

Via The Motley Fool

CRISPR Therapeutics Just Made History. So Why Did Its Stock Fall? ↗

December 16, 2023

The benefits from its first drug launch will trickle in slowly, at least at first.

Via The Motley Fool

3 Fantastic Stocks That Could Enjoy a Santa Claus Rally ↗

December 16, 2023

These stocks could bring investors more than just a lump of coal for Christmas.

Via The Motley Fool

Here's the 1 Key Reason You Might Want to Buy CRISPR Therapeutics Stock on the Dip ↗

December 16, 2023

This biotech could have more winners on the way.

Via The Motley Fool

Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development ↗

December 15, 2023

These pharma stock leaders offer revolutionary treatments that could change the world of medicine (and investor's portfolios) for the better.

Via InvestorPlace

3 Small-Cap Stocks That Could Skyrocket 1000% by 2030 ↗

December 14, 2023

With the iShares Russell 2000 ETF (NYSE:IWM) on the move, investors should consider these small-cap stocks to buy.

Via InvestorPlace

Topics ETFs

Cathie Wood Just Dumped $40 Million of Coinbase Global (COIN) Stock ↗

December 14, 2023

Wood is moving away from fintech and Internet names like COIN stock. She's now favoring genomics and artificial intelligence companies.

Via InvestorPlace

Topics Artificial Intelligence

1 Biotech Stock That Could Be the Next Amgen ↗

December 13, 2023

The emergence of genomic medicine as a viable modality could transform this midcap biotech into the next Amgen.

Via The Motley Fool

Better Growth Stock: Vertex Pharmaceuticals or Exact Sciences? ↗

December 13, 2023

Both of these biotech stocks have been market-beaters over the prior 10 years. One stock, however, is a better buy right now.

Via The Motley Fool

3 Gene-Editing Stocks With the Potential to Mint Millionaires ↗

December 13, 2023

Gene editing stocks are very likely to see a spike in demand over the coming weeks in the wake of FDA approval of CRISPR.

Via InvestorPlace

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

All News about CRISPR Therapeutics AG - Common Shares

Sections

Services

Contact Information

Follow Us